RxDoctor Payments Data

Traci Johns, NP

Nurse Practitioner · Athens, GANPI 1427315845

Payments from drug & device makers

$2,311in general payments, 2019–2025

Across 112 payments — averaging $20.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$413
  • Bayer$225
  • Astellas Pharma US Inc$214
  • Pfizer$164
  • Sumitomo Pharma America, Inc.$146
  • Boston Scientific$131
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$2,20595%
  • Education$1055%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,311 in reported general payments places this provider in the 85th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Medicare billing

Part B allowed, 2024
$31,269
Medicare patients
233
Services billed
659

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron29$17,290
MyrbetriqMirabegron14$11,545
Tamsulosin Hcl78$1,497
Estradiol11$924
Finasteride45$808
Methenamine Hippurate16$797
Oxybutynin Chloride ErOxybutynin Chloride13$576
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst25$232
Oxybutynin Chloride13$161
Cefdinir15$143
Ciprofloxacin Hcl19$96
Amoxicillin12$47

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$146$17,29029 claims
Astellas Pharma US IncMyrbetriq$214$11,54514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,328 nurse practitioner providers in Georgia.

Other nurse practitioner in Athens

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →